Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News BioSig Technologies Inc BSGM

Healthcare Medical Devices
BioSig Technologies, Inc. is a medical technology company focused on deciphering the body’s electrical signals, starting with heart rhythms. The Company’s product, the PURE EP Platform, a non-invasive class II device, provides real-time signal visualization allowing physicians to perform highly targeted cardiac ablation procedures. Integrating with existing systems in the EP lab, PURE EP is... see more

Recent & Breaking News (NDAQ:BSGM)

BioSig to Present at NobleCon18 Capital Markets Conference

GlobeNewswire April 7, 2022

BioSig Technologies, Inc. Partners with Summit Blue Capital to Provide Equipment Leasing Services

GlobeNewswire March 29, 2022

BioSig Announces Closing of Public Offering of Common Stock

GlobeNewswire March 23, 2022

BioSig Technologies, Inc. Announces $3 Million Financing with Family Office

GlobeNewswire March 22, 2022

BioSig Technologies, Inc. Appoints John Sieckhaus as Chief Operating Officer

GlobeNewswire March 16, 2022

BioSig Awarded US Patent Claims for its PURE EP(TM) Noise-Filtering Technology

GlobeNewswire January 26, 2022

BioSig to Present at the 27th Annual International AF Symposium

GlobeNewswire January 7, 2022

BioSig to Present at the 24th Annual Virtual Needham Growth Conference

GlobeNewswire January 6, 2022

BioSig Technologies, Inc. Selects Access Strategy Partners to Accelerate Commercial Sales

GlobeNewswire December 21, 2021

BioSig Expands Its Clinical Footprint In Florida

GlobeNewswire December 16, 2021

BioSig to Host Conference Call on December 21, 2021

GlobeNewswire December 13, 2021

BioSig to Participate in the Benzinga All Access Event on December 14, 2021

GlobeNewswire December 6, 2021

BioSig Technologies, Inc. Appoints Gray Fleming as Chief Commercial Officer

GlobeNewswire December 1, 2021

BioSig to Participate in the The Benchmark Company 10th Annual Discovery Conference

GlobeNewswire November 17, 2021

BioSig Initiates Artificial Intelligence Development Program with Technion - Israel Institute of Technology

GlobeNewswire November 16, 2021

BioSig to Host Live Roundtable Webinar to Discuss Clinical Data Delivered With Its Signal Processing Technology For Arrhythmia Care

GlobeNewswire November 11, 2021

BioSig Adds To Its Clinical Footprint In Texas

GlobeNewswire November 10, 2021

BioSig Installs its Signal Processing Technology for Arrhythmia Care at a Leading Hospital in Boston

GlobeNewswire November 8, 2021

BioSig Expands its Installation Base in Texas

GlobeNewswire November 4, 2021

BioSig Increases Case Volume Estimates

GlobeNewswire November 1, 2021